Merck corrects officer's holding to 2,871 shares
Maraldo's reported common-stock position was held indirectly through the Merck U.S. Savings Plan stock fund.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Merck & Co., Inc.'s Form 3/A corrects the reported common-stock holding of David R. Maraldo, an officer whose title is EVP & Pres. MMD, in the stock fund of the Merck U.S. Savings Plan. The corrected indirect holding was 2,871 shares as of May 1, 2026. The entry reports a holding balance rather than a purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock - 401(k) Plan F1 | -- | -- | -- |
Footnotes (1)
- F1. This Form 3/A is being filed solely to correct the number of shares of the Issuer's common stock considered to be held by the Reporting Person in the stock fund of the Merck U.S. Savings Plan, a 401(k) plan, as of May 1, 2026.
Key Figures
Key Terms
401(k) plan financial
stock fund financial
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.